Baxter International (BAX)

Price*: $51.21 | Dividend: $1.04 | Dividend Yield: 2.03%

Recommendation Info
We downgraded this stock from the "Recommended" list on 10/7/08, at a price of 64.64.

Dividend Stock Ratings Breakdown

1. Relative Strength

Stock is at the top of its six-month trading range.

2. Overall Yield Attractiveness

Stock's dividend yield is below average.

3. Dividend Reliability

This rating is directly related to the length and consistency of a company's dividend payouts.

4. Dividend Uptrend

Dividend payouts are consistent, but increases small.

5. Earnings Growth

Earnings estimates are basically unchanged.

Price and Dividend Info

Baxter International (BAX)

Previous Day's Closing Price*

$51.21

Annual Stock Dividend

$1.04

Current Dividend Yield

2.03%

Recent Headlines

Dividend Payout Changes Today (ADP, BAX, BOBE, MEE, PPDI, PRU, CBBO)
Tue, Nov 11, 2008
Baxter International Boosts Guidance on 16% Revenue Gain (BAX)
Thu, Oct 16, 2008
20 Dividend Stocks Removed from Our Recommended List
Tue, Oct 7, 2008
Dividend Stock Recommendation Changes (BAX, APH, PNC, BLK, IIIN, NUE, CMC, BHP, ACI, STO, ZEUS, MT, CNX)
Thu, Jul 17, 2008

Profile & Recommendation

Company Profile

Baxter- (BAX)-assists healthcare professionals and their patients with the treatment of complex medical conditions, including cancer, hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other medical conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives. Baxter International was founded in 1931 and is based in Deerfield, Illinois.

Recommendation

Based on our rating criteria, this stock has achieved a "Neutral" rating. Stocks with a neutral rating are considered mediocre investments in terms of expected price growth and dividend payments.

Stock Notes

This large cap stock is not an attractive dividend stock investment at this time.

* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.

** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.